Source: Annual Congress 2002 - Pulmonary surfactant in the pathogenesis and treatment of acute respiratory failure
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. L. Baradzina, I. L. Kotovich, A. D. Taganovich, G. N. Tamashakina (Minsk, Belarus). Influence of ambroxol for the phospholipid composition of surfactant in pulmonary sarcoidosis. Eur Respir J 2002; 20: Suppl. 38, 2338

Member's Comments

No comment yet.

Related content which might interest you: Effect of surfactant phospholipids on human eosinophils Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009 Changes in pulmonary surfactant composition during bleomycin-induced lung injury Source: Eur Respir J 2006; 28: Suppl. 50, 397s Year: 2006 Essential phospholipids in pulmonary sarcoidosis Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008 Effect of inhaled antioxidants on surfactant phospholipids under prolonged experimental hyperoxia Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 What influence surfactant composition? Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 The influence of intratracheal surfactant-BL administration or [DCquote]empty“ phosphatidylcholine liposomes on lung surfactant level and alveolar macrophage activity in intact rat lungs Source: Eur Respir J 2003; 22: Suppl. 45, 73s Year: 2003 Surfactant proteins in pulmonary alveolar proteinosis in adults Source: Eur Respir J 2004; 24: 426-435 Year: 2004 Influence of natural lung surfactant inhalations on clinical symptoms and pulmonary function parameters in patients with bronchial asthma Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018 Effect of inhaled surfactant enriched with phosphatidylethanolamine on matrix deposition in a murine model of airway inflammation and remodeling. Source: International Congress 2018 – Basic pharmacology Year: 2018 Influence the phosphatidylcholine treatment program on surfactant protein D levels in hypertensive patients with community-acquired pneumonia Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018 Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties Source: Eur Respir J 2002; 19: 797-804 Year: 2002 Effect of pulmonary hypertension on gas exchange in patients with sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003 Effect of pulmonary rehabilitation on body composition in patients with COPD Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009 Changes of the lipid spectrum of pulmonary surfactant in patients with chronic obstructive bronchitis of miners Source: Eur Respir J 2002; 20: Suppl. 38, 256s Year: 2002 Effect of different ventilation techniques on surfactant stability and metabolism Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs) Year: 2009 Vitamin supplement-therapy and lipid hyper oxidation marker in pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 453s Year: 2005 Abnormal intraalveolar accumulation of surfactant proteins in adults with pulmonary alveolar proteinosis Source: Eur Respir J 2002; 20: Suppl. 38, 90s Year: 2002 Serum lipid profile and iron content in serum and pulmonary tissue in experimental pulmonary emphysema Source: Annual Congress 2011 - Recent developments in COPD Year: 2011